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A recent report by the Royal College of General Practitioners in the UK documented an agestandardised person prevalence rate of 182 per 10,000 for acute pharyngitis in the year 2007. Furthermore, they reported a patient consultation rate of 182 per 10,000 persons for all ages (6) . Current recommendations are to avoid unnecessary prescribing of antibiotics (7) (8) (9) (10) . Therefore, an understanding of the leading causes of sore throat and the availability of effective over-the-counter (OTC) treatment options as a recommendation for patients who present at surgeries, are becoming increasingly important.
Causes of acute sore throat
Viruses have been associated with 50-95% of sore throats in adults (11, 12) , and linked to 70% of sore throats in children between the ages of 5−16 years, and 95% in under 5s (12) .
The viral causes of sore throat are numerous and include respiratory viruses such as respiratory syncytial viruses, rhinoviruses and influenza A (13, 14) . A global analysis of the prevalence of patients with human influenza (H1N1 virus) reporting sore throat as a symptom ranged from 26% (in the UK) to 39% (in Japan) (1).
It is possible that bacterial causes may be underestimated and may contribute up to 20% of all sore throat aetiologies (15) . Therefore, it is important that cases of sore throat due to streptococcal infections are correctly identified with appropriate antibiotics prescribed. Other humidity, smoking, air pollution and a reaction to allergens, among other factors (7).
Pro-inflammatory cytokines and acute sore throat
Irrespective of the cause, a sore throat manifests as irritating symptoms such as pain and irritation, and is most likely to be caused by inflammatory mediators, e.g. bradykinin and
prostaglandins, which are released following local responses to cell damage and exert their effect on sensory nerves in the airways (16) . In addition, pro-inflammatory cytokines have been associated with sickness behaviour (17) , which, in turn, is associated with increased pain sensitivity in cases of microbial infection (17) . Because most sore throats are infective in nature and sore throat-induced pro-inflammatory cytokines are linked with sickness behaviour, there may be potential implications to the quality of life of sufferers where there is associated viral or bacterial infection. A study in young adults with suspected viral sore throat has demonstrated a high correlation between sore throat and 'sickness' (18) .
Furthermore, it has been found that sore throats have a significant impact on normal daily activities/functions of a patient, including swallowing, talking, eating a meal, sleeping and concentration (19) .
Associated cost burden
Despite the high predominance of viral sore throats over any other causes in adults (11, 12) , antibiotics are commonly prescribed by physicians for the treatment of acute sore throats (20, 21) . Throughout the 1980s, there was a progressive increase in the overall consumption of antibiotics in the UK (20, 22) . Although this number fell by 45% in the mid-1990s, in the year 2000, antibiotics were still prescribed to over two-thirds of patients presenting to general practice with respiratory tract infections; 60% of whom had sore throat (20) .
It is now generally recognised that antibiotics have limited efficacy in the majority of patients with acute sore throats (7, 21) , and may encourage repeated attendance for future sore throat episodes (23 
Self-management of acute sore throat
Most cases of acute sore throat can be managed effectively by the patient who does not present with signs of complications such as fever and difficulty in breathing (with the exception of children). The management of acute sore throat revolves around providing relief from existing symptoms (e.g. local pain and inflammation), removal of the underlying causes and the prevention of secondary complications (3). Self-management of non-complicated, simple cases of acute sore throat is possible through the use of analgesic, local anaesthetic, antiseptic and anti-inflammatory agents.
Available OTC sore throat remedies and the different formulations
Compared with oral analgesic treatments, topical remedies such as throat lozenges, gargles and throat sprays (3), which are applied directly to the mucous membranes of the mouth or throat, can provide more rapid symptomatic relief in patients with acute sore throat. There are clear differences between the three topical delivery systems in the onset of action and the amount of active ingredients present in the mouth and throat. Throat sprays should ideally produce relatively coarse droplets so that they reach the desired target site. However, a proportion of the spray is immediately swallowed after application (24), thus reducing the concentration of active ingredients present in the mouth and throat. In addition, evidence suggests that owing to the gag reflex, gargles are not able to deliver the active ingredients to all areas of the throat and only deliver to the anterior oral cavity (25).
Lozenges are placed in the oral cavity where they slowly dissolve to release the active ingredients directly onto the irritated mucosal tissues. As the lozenge dissolves in the mouth, the mouth adopts a reservoir-like role for the distribution of the lozenge contents to the throat (24). Therefore, medicated throat lozenges have the added advantage of being slowreleasing. Furthermore, the portability and convenience of taking lozenges may help to facilitate good adherence/compliance to medication.
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Important features of some topical OTC sore throat remedies
We propose that an ideal sore throat treatment, or a range of treatment products, should possess the following properties:
• Targets the causes of throat soreness, especially the viral causes and inflammation
• Provides local pain relief, eliminating the associated discomfort in the throat region
• Provides a rapid onset of action from the time that the remedy is taken or administered
• Has a prolonged duration of action, given the actual and patient-perceived prolonged nature of sore throat symptoms
• Be shown to be effective over a range of different types of sore throat (e.g. from the scratchy-like sensation causing local discomfort to the painful sore throats with a 'raw' feeling and to the inflamed, swollen throat types of sore throat)
• Should address the emotional aspects of having a sore throat by helping patients to feel better • Should have a good safety profile
We will now consider these seven characteristics in greater detail.
Targeting the causes of sore throat
Several antiviral drugs of the neuraminidase inhibitor class have been shown to block the replication of influenza in the upper airways (14, 50) , and thereby reduce the symptoms, including those of sore throat. However, although antiviral treatments may have a pivotal place in the treatment of URTIs (51), they are bound by several limitations. For example, they are limited by the specific nature of antiviral drugs, the fact that new strains are constantly emerging, the length of time an anti-infective takes to work and the subsequent level of reduction in inflammation that is required before clinical benefits prevail. Moreover, from the viewpoint of a patient, being able to feel well quickly is of primary importance, and so the availability of treatment (i.e. OTC, for easy access and self-management) that targets the underlying causes of sore throat to provide rapid symptomatic relief is key. Ideally, such treatments would target both the viral and inflammatory causes because evidence suggests that antiviral without anti-inflammatory effects have little symptomatic benefit for patients with a cold (52) . 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58 
Pain relief
Local symptomatic pain relief plays an important role in the management of acute sore throat (51) . The influence of pro-inflammatory mediators on the pain sensation of all sore throats regardless of the cause need to be taken into consideration when making treatment choices, and should also be a target for providing symptomatic relief of symptoms, thereby reducing associated inflammation and pain.
The analgesic effect experienced with antiseptic lozenges such as AMC/DCBA throat lozenges was thought to be produced by means of its antiseptic action on bacteria and viruses ( Figure 1) (13,53,54) . In vitro evidence demonstrated the virucidal effect of AMC and DCBA on a number of viruses associated with common cold/flu (13) , and it could be anticipated that reduction of virus infectivity in saliva would reduce virus transmission to others in addition to the immediate clinical benefits of reducing soreness. However, clinical trials and human quarantine experiments would be needed to precisely quantify the antiviral effects of any lozenge in vivo.
However, recent evidence has led to the theory that such pain relief was not merely as a result of antiseptic and demulcent/moisturising action -a possible sodium channel-blocking effect was deemed to be a contributory factor and a viable mechanistic pathway (29) .
Sodium channels, as mediators of membrane excitability, regulate the sodium permeability of cells during the rapid rising phase of the action potential. These channels play a key role in initiation and transmission of electrical activity throughout the nervous system, with implications for sensory neuron physiology and pathophysiology, and localised inhibition of their function can prevent the perception of pain (55, 56) . Therefore, sodium channels are thought to represent key target sites for local anaesthetic agents, such as lidocaine, to exert their analgesic effects.
Based on previous work on sodium channel-blocking properties of phenol derivatives (57−59), we hypothesised that the analgesic effect of antiseptics which carry the aromatic alcohol phenol as the core element (see Figure 2 ) might actually -at least partly -be due to sodium channel blocking, i.e. direct local anaesthetic-like effects.
In particular, the proposition was examined that the active ingredients AMC, DCBA and hexylresorcinol present in some antiseptic lozenges act in this manner. When the in vitro effect of AMC, DCBA and hexylresorcinol in blocking voltage-operated neuronal sodium channels heterogeneously expressed in human embryonic kidney 293 cells was investigated (29) , all three agents were found to block voltage-gated sodium channels in a local In addition, real-life patient experiences reported during clinical trials have demonstrated that AMC/DCBA-containing lozenges exert significantly greater reductions in mean throat discomfort levels (60), severity of throat soreness (19,60−62) , offering greater pain relief (19,60−62) and easing of difficulty in swallowing (19) to sore throat sufferers compared with non-medicated placebo lozenges. Furthermore, the analgesic effects of AMC/DCBA throat lozenges were clinically meaningful compared with non-medicated lozenges (19) , and significant improvements in functional impairment scores were observed for swallowing, talking and eating a meal (19) . Importantly, this evidence suggests that effective OTC treatments are available that not only provide effective relief of the physical symptoms, but also improve functional impairment, thus allowing patients to re-engage in their daily activities and return to their everyday lives (19) .
Speed of action
When evaluating the suitability of sore throat remedies, the simple demulcent benefits should not be overlooked because demulcents, such as glycerin, honey and sugar (which form the base of throat lozenges), act to soothe the throat and reduce the irritation (2). In addition, the increased production of saliva induced by the sucking action required with lozenges that becomes evident after 1 minute (63) provides lubrication to the throat to soothe inflammation (2) . Saliva production may also flush the offending microbes from the throat surface (2) . Furthermore, the antiviral and antifungal constituents of saliva may protect tissues by targeting microbes, encouraging soft tissue repair, maintaining an ecological balance in the oral region and maintaining an adequate pH (64) . Previous research has shown that AMC/DCBA-containing throat lozenges administered to healthy volunteers promote saliva production (63) .
Scintigraphy studies have highlighted transit and deposition sites in the throat and have shown that the lozenge formulation can facilitate the delivery of active ingredients to the 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 F o r P e e r R e v i e w O n l y 9 throat at a similar rate to a spray and at a greater rate than a gargle, and at a concentration that was maintained for longer than the spray or gargle (24).
In general, rapid sensorial effects (i.e. relief that is soothing and comforting) can impact the overall speed of treatment benefit, and is thus key to the perceived efficacy of a sore throat remedy. However, the sensorial effects will also need to be supported by rapid analgesic relief provided by the active ingredients -this separation of effect can be seen with AMC/DCBA throat lozenges (19) . Furthermore, because the natural clinical course of sore throats is often 6-8 days (18), untreated patients often endure persistent pain, irritation or other unpleasant sensory experiences over a prolonged period of time.
The duration of action
Therefore, having a long duration of action is an essential prerequisite of any remedy used.
Limb et al. have demonstrated that lozenges offer a relatively prolonged activity (23) .
Gargles are usually gargled in the mouth for approximately 30 seconds and then are expelled whereas sprays are swallowed soon after application, but lozenges take approximately 6-9 minutes to dissolve in the mouth upon sucking (63) . Scintigraphy research has shown that lozenges are an ideal vehicle for sore throat treatment owing to their reservoir-like action, offering rapid and prolonged delivery of active ingredients (24).
Furthermore, studies have demonstrated that continued use of AMC/DCBA throat lozenges over a 3-day period provides significantly greater improvements in throat soreness, faster pain relief and greater easing of difficulty in swallowing compared with non-medicated lozenges (19) .
Effectiveness over a range of different types of sore throat
Sore throats exhibit themselves in different ways depending on the individual and the causative factors. A combination of antiseptic, analgesic and anti-inflammatory properties of medicated lozenges, and stimulation saliva production are important attributes for a sore throat lozenge. (19) . This begins to address the emotional aspects of having a sore throat. When patients feel better, they can get back to and carry on with their everyday lives.
Safety profile
The literature available on topical OTC sore throat treatments demonstrates a good safety profile, with only very minor self-limiting adverse effects, such as headaches and coughing being reported. However, a systematic review is warranted to further evaluate this.
Additionally, it is important to note that patients should take care when drinking hot beverages if using strong anaesthetics, because the local numbing effect may result in patients underestimating the exact temperatures.
Conclusions
Sore throat is considered a minor ailment but results in considerable suffering for the patient who then seeks remedial action, often at the expense of the healthcare system. A reduction in antibiotic prescribing, especially for respiratory conditions such as sore throat, is currently on the agenda of many global healthcare services to minimise bacterial resistance and unnecessary exposure of patients to potential side effects (7) (8) (9) 20) , which in turn reduces costs. In the UK, NHS Direct has encouraged self-diagnosis and along with the mild symptoms (including sore throat) experienced by most, the extensive OTC range of medicines, such as analgesics and sore throat lozenges has played an important clinical role in communities around the world.
An 'ideal' OTC treatment for sore throat should have a minimum set of features that would render it clinically effective in providing pain relief and have additional benefits, such as those of sensorial stimulation. These 'ideal' characteristics -targeting the underlying causes, providing pain relief, having a rapid onset of action or prolonged duration and being effective over a range of different sore throat types such that the patient feels better after treatmentshould be borne in mind when making a treatment recommendation to patients, given the evidence available. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 
